spacer
home > ict > winter 2019 > the evolution of environmental monitoring
PUBLICATIONS
International Clinical Trials

The Evolution of Environmental Monitoring

Clinical trials are a complex undertaking and a huge investment for the sponsor, taking a significant amount of time to complete and to produce a marketable drug. Added complexity comes from the inherently global nature of recent clinical trials which are spreading operations over multiple nations, sites, and premises. Ensuring sufficient enrolment numbers and monitoring activities on multiple sites and suchlike justifiably take up a major portion of sponsor and investigator focus.

A Complicated Process

With the vast amount of analytical activities in a clinical study, it is easy to forget that even in national – and more so, in international studies – logistics complexity is a major concern. However, while logistics is a support function for the overall trial operation, it also needs planning to function efficiently.

In a drug trial, ensuring that the investigational medicinal products (IMPs) reach the site in good condition and that samples travel from collection points to laboratories in correct environments is paramount. With lab specialisation requiring long transportation distances and the parallel supply chains of international, regional, and local hubs often working without visibility to each other, guaranteeing the integrity of the supply is not always easy.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer
Jukkapekka ‘JP’ Asikainen is the founder and CEO at Sensire. He is a leading expert on the cold supply chain and an accomplished innovator of marketleading wireless monitoring solutions for pharma logistics, healthcare services, and processing and manufacturing operations. JP is a highly successful serial entrepreneur and has over 30 years’ experience in executive management, marketing and sales. As a longtime specialist on environmental monitoring systems, JP is exceedingly experienced at providing customers with real-life solutions to real-world challenges.

Ossi Laakkonen is Technical Director at Sensire. He is an expert in cold supply chain technology design and accomplished in designing robust and comprehensive environmental monitoring systems for a wide variety of applications. Ossi’s speciality is in the field of IoT and he has over 10 years of experience with working on wireless sensor network research and development. He also holds several groundbreaking patents on these technologies.
spacer
Jukkapekka ‘JP’ Asikainen
spacer
spacer
spacer
Ossi Laakkonen
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

European Commission Approves BYANNLI® (6-monthly Paliperidone Palmitate; PP6M) for the Maintenance Treatment of Schizophrenia in Adults

 BYANNLI® (6-monthly paliperidone palmitate; PP6M) is the first long-acting injectable schizophrenia treatment to be approved with a twice-yearly dosing regimen[1] . The approval is based on results from the Route 6 Study, which showed that 92.5 percent of patients treated with PP6M were relapse-free at the end of the 12-month double-blind phase1.  
More info >>

White Papers

Role of Comparators in Clinical Trial Supply

Clinical Services International

CSI analyses the role of comparators in different trial designs and offers expert advice on robust methodology for choosing the most appropriate comparators. Case studies provide real insight on how to choose comparators for rare diseases and oncology studies.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement